Cargando…
Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
SIMPLE SUMMARY: The overall 5-year survival rate of esophageal cancer patients is poor. Galectins are glycan-binding proteins known to contribute to tumor initiation and progression. To get insight in the expression and potential function of galectins in esophageal cancer we performed a literature r...
Autores principales: | Godefa, Tesfay M., Derks, Sarah, Thijssen, Victor L. J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736038/ https://www.ncbi.nlm.nih.gov/pubmed/36497271 http://dx.doi.org/10.3390/cancers14235790 |
Ejemplares similares
-
Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
por: Wdowiak, Kamil, et al.
Publicado: (2018) -
Esophageal lichen planus: Current knowledge, challenges and future perspectives
por: Decker, Annegrit, et al.
Publicado: (2022) -
Galectins in Endothelial Cell Biology and Angiogenesis: The Basics
por: Thijssen, Victor L.
Publicado: (2021) -
Galectin 3: an extraordinary multifunctional protein in dermatology.
Current knowledge and perspectives
por: Pasmatzi, Efstathia, et al.
Publicado: (2019) -
Sclerostin: Current Knowledge and Future Perspectives
por: Moester, M. J. C., et al.
Publicado: (2010)